medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 6

<< Back Next >>

Salud Mental 2017; 40 (6)

Ibero-American initiative for dual disorders to improve public treatment programs

Alfonzo-Bello L, Szerman N, Marín-Navarrete R, Arribas-Ibar E, Pérez-Lopez A, Babín F, Medina-Mora ME
Full text How to cite this article

Language: Spanish
References: 25
Page: 249-255
PDF size: 178.88 Kb.


Key words:

Dual disorders, substance use disorder, mental disorders, addictions, Ibero-American countries.

ABSTRACT

Introduction. Dual disorders (DD) are defined as the co-occurrence of substance use disorders with other psychiatric disorders across the lifespan. DD represent a diagnostic dimension with clinical peculiarities and specific healthcare needs, which raises the need to implement integrative treatment algorithms. However, worldwide, most programs address this condition through serial or parallel approaches. In Latin America, as in the rest of the world, there is no health care network that adequately addresses this problem. Objective. To describe the development of the initiative for the integral treatment of DD in Latin America. Method. The Organización Panamericana de la Salud (Pan American Health Organization), together with other collaborating organizations, implemented a three-stage plan for developing a regional initiative: 1. meeting of DD experts, 2. review of the literature on DD, and 3. identification of services for DD care in Latin America. Results. The creation of the Iniciativa Iberoamericana para la Patología Dual (Ibero-American Initiative for Dual Disorders) seeks to implement four lines of action to improve of public services: a) build a theoretical-conceptual consensus on DD, b) propose a treatment model, c) develop skills-based training, and d) create collaborative networks for research on DD. Discussion and conclusion. The following actions include the formation of working groups to create a regional collaborative network, discuss the role of participating organizations and establish guidelines for the implementation of the initiative.


REFERENCES

  1. Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babín, F. (2013). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25(1), 118-127.

  2. Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004). The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? The American Journal of Psychiatry, 161(12), 2163-2177. doi: 10.1176/appi. ajp.161.12.2163

  3. Blumenthal, D., Gokhale, M., Campbell, E. G., & Weissman, J. S. (2001). Preparedness for clinical practice: reports of graduating residents at academic health centers. JAMA: The Journal of the American Medical Association, 286(9), 1027- 1034. doi: 10.1001/jama.286.9.1027

  4. Center for Behavioral Health Statistics and Quality (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Retrieved from: http://www.samhsa.gov/data/

  5. Dansky, B. S., Roitzsch, J. C., Brady, K. T., & Saladin, M. E. (1997). Posttraumatic stress disorder and substance abuse: Use of research in a clinical setting. Journal of Traumatic Stress, 10(1), 141-148. doi: 10.1002/jts.2490100114

  6. Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24(4), 589-608. doi: 10.1093/oxfordjournals.schbul.a033351

  7. Fixsen, D., Naoom, S., Blase, K., Friedman, R., & Wallace, F. (2005). Implementation Research: A synthesis of the Literature. Tampa: University of South Florida, Louis de la Parte Florida Mental Health Institute.

  8. Foster, S., LeFauve, C., Kresky-Wolff, M., & Rickards, L. D. (2010). Services and supports for individuals with co-occurring disorders and long-term homelessness. Journal of Behavioral Health Services and Research, 37(2), 239-251. doi: 10.1007/s11414-009-9190-2

  9. Huang, S. L., Hsieh, C. L., Wu, R. M., & Lu, W. S. (2017). Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson’s disease. Plos One, 12(9), e0184823. doi: 10.1371/journal.pone.0184823

  10. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17-31. doi: 10.1037/h0080151

  11. Lobbestael, J., Leurgans, M., & Arntz, A. (2011). Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clinical Psychology & Psychotherapy, 18(1), 75-79. doi: 10.1002/cpp.693

  12. Magán, I., Sanz, J., & García-Vera, M. P. (2008). Psychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general population. The Spanish Journal of Psychology, 11(2), 626-40.

  13. Marín-Navarrete, R., Benjet, C., Borges, G., Eliosa-Hernández, A., Nanni-Alvarado, R., Ayala-Ledesma, M., … & Medina-Mora, M. E. (2013). Comorbilidad de los trastornos por consumo de sustancias con otros trastornos psiquiátricos en Centros Residenciales de Ayuda-Mutua para la Atención de las Adicciones. Salud Mental, 36(6), 471-479.

  14. Marín-Navarrete, R., & Szerman, N. (2015). Repensando el concepto de adicciones: pasos hacia la patología dual. Salud Mental, 38(6), 395-396. doi: 10.17711/ SM.0185-3325.2015.60

  15. Marín-Navarrete, R., Medina-Mora, M. E., Horigian, V. E., Salloum, I. M., Villalobos- Gallegos, L., & Fernández-Mondragón, J. (2016a). Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use. Journal of Dual Diagnosis, 12(3-4), 261-270. doi: 10.1080/15504263.2016.1220207

  16. Marín-Navarrete, R., Szerman, N., Toledo-Fernández, A., Villalobos-Gallegos, L., Pérez-López, A., Brzezinski, A., & Lezama-Bautista, A. (2016b). Estado de la Evidencia sobre Patología Dual en Latinoamérica. Poster presented at the 18° Congreso Internacional en Adicciones de Centros de Integración Juvenil, Acapulco, México.

  17. Marín-Navarrete, R., Magis-Rodríguez, C., & Strathdee, S. A. (2017). Sexually transmitted infections and substance use disorders: evidence and challenges in Mexico. Salud Mental, 40(1), 1-4. doi: 10.17711/SM.0185-3325.2017.001

  18. Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review. Journal of Substance Abuse Treatment, 61, 47-59. doi: 10.1016/j. jsat.2015.09.006

  19. Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., … & Towle, L. H. (1988). The Composite International Diagnostic Interview. Archives of General Psychiatry, 45(12), 1069-1077. doi: 10.1001/archpsyc. 1988.01800360017003

  20. Substance Abuse and Mental Health Services Administration & Center for Substance Abuse Treatment (2005). Substance Abuse Treatment for Persons With Co-Occurring Disorders: A Treatment Improvement Protocol (TIP) Series 42. Rockville: Substance Abuse and Mental Health Services Administration.

  21. Sheehan, D. V., Lecrubier, Y., Harnett, K., Janavs, J., Weiller, E., Keskiner, A., … & Dunbar, G. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12(5), 232-241. doi: 10.1016/S0924-9338(97)83297-X

  22. Szerman, N., Martinez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1), 1-10. doi: 10.1097/ADT.0b013e31826e7b6a

  23. Teesson, M., Degenhardt, L., Proudfoot, H., Hall, W., & Lynskey, M. (2005). How common is comorbidity and why does it occur? Australian Psychologist, 40(2), 81-87. doi: 10.1080/00050060500094605

  24. Torrens, M., Mestre-Pintó, J. I., & Domingo-Salvany, A. (2015). Comorbidity of substance use and mental disorders in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

  25. Vega, P., Szerman, N., Roncero, C., Grau-López, L., Mesías, B., Barral, C., … & Casas, M. (2015). Recursos y Necesidades Asistenciales en Patología Dual. Madrid: Sociedad Española de Patología Dual. 26. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361-70.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2017;40